Home - Australian Pharmacist

Whitfield’s ointment

AP Staff - 9 October 2000

Clinical

Homei A, Worboys M. Fungal Disease in Britain and the United States 1850–2000: Mycoses and Modernity. Chapter 2: Athlete’s foot: a disease of...

Persistent pelvic pain

Jennifer Cooke - 11 December 2000

Clinical

References Endometriosis Australia. About Endometriosis. At: endometriosisaustralia.org/about-endometriosis1/ Crump L, Suker A, White L. Endometriosis: A review of recent evidence and guidelines. AJGP. 2024....

Endometriosis: more than just a bad period

AP Staff - 17 December 2000

CPD

References Therapeutic Guidelines Limited. Endometriosis. In: eTG complete. Melbourne: Therapeutic Guidelines Limited; 2024. At: www.tg.org.au Burney RO, Giudice LC. Pathogenesis and pathophysiology of...

Summer of fun?

AP Staff - 28 November 2000

Advertorial

RB - 31 October 2000

How does the nasal spray differ from EpiPen?

Can it be placed in a resuscitation kit?

Who is the nasal spray best suited to?

What should pharmacists know about its use?

Who is most likely to experience adverse effects?

Who might find it hard to use the nasal spray?

Could adrenaline nasal spray (neffy) be downscheduled?

How much does it cost?

Will the nasal spray be PBS listed?

Where can I find more information?

Bridging the gap when CBT is delayed

Checking duration against intention

Monitoring efficacy and tolerability

Chronic vs acute pelvic pain

Case 1

Case 2

What’s the purpose of the service?

How will urgent ADHD ‘repeats’ be issued?

Who will be eligible?

What are the safeguards?

Part of a broader national shift

1. Not recommending ulipristal as first-line

2. Uncertainty when responding to third-party requests

3. Uncertainty providing emergency contraception to adolescents

4. Uncertainty for transgender people on gender affirming hormone therapy

Another reason the APF is a mandatory text for all community pharmacists

Delivering a critical intervention

How does the nasal spray differ from EpiPen?

Can it be placed in a resuscitation kit?

Who is the nasal spray best suited to?

What should pharmacists know about its use?

Who is most likely to experience adverse effects?

Who might find it hard to use the nasal spray?

Could adrenaline nasal spray (neffy) be downscheduled?

How much does it cost?

Will the nasal spray be PBS listed?

Where can I find more information?

Bridging the gap when CBT is delayed

Checking duration against intention

Monitoring efficacy and tolerability

Chronic vs acute pelvic pain

Case 1

Case 2

What’s the purpose of the service?

How will urgent ADHD ‘repeats’ be issued?

Who will be eligible?

What are the safeguards?

Part of a broader national shift

1. Not recommending ulipristal as first-line

2. Uncertainty when responding to third-party requests

3. Uncertainty providing emergency contraception to adolescents

4. Uncertainty for transgender people on gender affirming hormone therapy

Another reason the APF is a mandatory text for all community pharmacists

Delivering a critical intervention

How does the nasal spray differ from EpiPen?

Can it be placed in a resuscitation kit?

Who is the nasal spray best suited to?

What should pharmacists know about its use?

Who is most likely to experience adverse effects?

Who might find it hard to use the nasal spray?

Could adrenaline nasal spray (neffy) be downscheduled?

How much does it cost?

Will the nasal spray be PBS listed?

Where can I find more information?

Bridging the gap when CBT is delayed

Checking duration against intention

Monitoring efficacy and tolerability

Chronic vs acute pelvic pain

Case 1

Case 2

What’s the purpose of the service?

How will urgent ADHD ‘repeats’ be issued?

Who will be eligible?

What are the safeguards?

Part of a broader national shift

1. Not recommending ulipristal as first-line

2. Uncertainty when responding to third-party requests

3. Uncertainty providing emergency contraception to adolescents

4. Uncertainty for transgender people on gender affirming hormone therapy

Another reason the APF is a mandatory text for all community pharmacists